Various autologous ‘regenerative’ approaches have emerged in the last 20 years, such as Platelet Rich Plasma (PRP) therapy and Stromal Vascular Fraction (SVF) therapy.

PRP & SVF have been marketed as ‘regenerative’ therapies. They are early examples of ‘autologous regeneration’ with low levels of sophistication and efficacy difficulties. PRP is a tool and not a standalone therapy.